CD276 is a biomarker for the prognosis of clear cell renal cell carcinoma

This study aims to investigate the role of cluster of differentiation 276 (CD276) in evaluating the prognosis of clear cell renal carcinoma (ccRCC) and build a nomogram for predicting the progression of ccRCC post-surgery.